Company news
Panbela Therapeutics, Inc. news in 2018
Panbela Therapeutics, Inc.'s news releases, calls and decks from 2018, newest first.
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q3 2018
November 5, 2018
Sun BioPharma, Inc. to Present Results of New Pancreatitis Study at American Pancreatic Association Meeting in Miami Beach, FL
November 1, 2018
Sun BioPharma, Inc. Announces Leadership Changes
October 31, 2018
Sun BioPharma, Inc. Provides a Business Update and Files Report for Q2 2018
August 13, 2018
Sun Biopharma, Inc. Presents Poster at Pancreasfest in Pittsburgh, Pa.
July 27, 2018
Sun BioPharma, Inc. Doses First Patients in Second Clinical Study of SBP-101 for Pancreatic Ductal Adenocarcinoma
June 13, 2018
Sun BioPharma Provides Business Update and Files Report for Q1 2018
May 14, 2018
Sun BioPharma, Inc. Announces Appointment of Susan Horvath as Vice President of Finance and Chief Financial Officer
April 16, 2018
Sun BioPharma Provides Business Update and Files Annual Report for 2017
March 21, 2018
Sun Biopharma, Inc. Files United States Patent Protecting the Manufacturing Process for Its Lead Drug Candidate, SBP-101
February 27, 2018
Sun Biopharma, Inc. Announces Initiation of First-Line Combination Study of Sbp-101 With Gemcitabine and Nab-Paclitaxel in Patients With Pancreatic Cancer
January 29, 2018